|
2024
|
Invention
|
Compound as androgen receptor (ar) antagonist and use thereof. Provided are a compound as shown i... |
|
|
Invention
|
Irak4 targeted degradation agent compound, and use thereof. The present disclosure relates to a I... |
|
|
Invention
|
Degradation agent compound targeting irak4, and use thereof. Provided are a degradation agent com... |
|
|
Invention
|
Amide compounds. Provided are compounds of formula (I) or stereoisomers or pharmaceutically accep... |
|
|
Invention
|
Compound acting as androgen receptor antagonist. Provided are a compound represented by formula (... |
|
2023
|
Invention
|
Compound and use thereof in preventing or treating radiation damage. The present invention provid... |
|
|
Invention
|
Ligand-drug conjugate and use thereof. nn or a pharmaceutically acceptable salt thereof, a prepar... |
|
|
Invention
|
Combination of prmt5 inhibitor and anti-cancer therapeutic agent. The present invention provides ... |
|
2022
|
Invention
|
Pharmaceutically acceptable salt of tetrahydroisoquinoline compound, and crystal form and use the... |
|
|
Invention
|
Bcma antibody and use thereof. The present invention relates to an antibody against a B-cell matu... |
|
|
Invention
|
Anti-bcma nanobody and use thereof. An antibody, or an antigen-binding fragment of same, specific... |
|
|
Invention
|
Brm selective degradation agent compound and use thereof. The present disclosure relates to a pro... |
|
|
Invention
|
Il-15 mutant fusion protein pharmaceutical composition. Disclosed is an IL-15 mutant fusion prote... |
|
|
Invention
|
Multi-specific antibody and pharmaceutical use thereof. A multi-specific antibody and a pharmaceu... |
|
|
Invention
|
Salt of pyrrolidine compound, crystal form thereof, and preparation method therefor. A pharmaceut... |
|
|
Invention
|
Drug combination for treating tumor, and application thereof. A drug combination comprising a com... |
|
|
Invention
|
Sirpa mutant and application thereof. Provided is a high affinity SIRPa polypeptide, comprising a... |
|
|
Invention
|
Anti-muc17 nanobody and use thereof. Disclosed is an antibody or an antigen-binding fragment ther... |
|
|
Invention
|
Heterocyclic compound as sos1 inhibitor and uses thereof. Provided are a class of heterocyclic co... |
|
|
Invention
|
Anti-human cd3 antibody and use thereof. Provided are an anti-human CD3 antibody and the use ther... |
|
|
Invention
|
Use of docetaxel polymer micelle in preparation of drug for preventing or treating malignant hydr... |
|
|
Invention
|
Purification method for amphiphilic block copolymer. A purification method for an amphiphilic blo... |
|
|
Invention
|
Hydrophobic drug polymer micelle and preparation method therefor. Provided is a polyethylene glyc... |
|
|
Invention
|
Camptothecin derivative, and pharmaceutical composition and use thereof. Provided are a compound ... |
|
|
Invention
|
Amide compound and use thereof. A compound of formula (I), or a stereoisomer or pharmaceutically ... |
|
|
Invention
|
Cd16 antibody and application thereof. The present disclosure relates to a CD16 antibody and an a... |
|
|
Invention
|
Anti-pvrig/anti-tigit bispecific antibody and application. Provided is a bispecific antibody capa... |
|
|
Invention
|
Cd19 antibody and application thereof. A CD19 antibody and an application thereof, an antibody or... |
|
|
Invention
|
Cd16 antibody and use thereof. The present invention relates to a CD16 antibody and the use there... |
|
|
Invention
|
Steroid compound, and pharmaceutical composition thereof and use thereof.
A compound as represen... |
|
|
Invention
|
Steroid compound, and pharmaceutical composition thereof and use thereof. A compound as represent... |
|
|
Invention
|
Anti-human msln humanized antibody and use thereof. The present invention relates to an anti-huma... |
|
|
Invention
|
Bifunctional fusion protein molecule containing anti-human il-17 antibody and taci. A bifunctiona... |
|
|
Invention
|
Anti-msln antibody and application thereof. An anti-MSLN antibody, a preparation method therefor,... |
|
|
Invention
|
Alkyne compound as hpk1 inhibitor and use thereof. Provided in the present invention are a compou... |
|
|
Invention
|
Anti-human serum albumin (hsa) nanobodies and applications thereof. Nanobodies specifically bindi... |
|
|
Invention
|
Garp/tgfβ1 antibody and use thereof. An antibody specifically binding to a GARP/TGFβ1 compound or... |
|
|
Invention
|
New sos1 inhibitor, preparation method therefor and use thereof. An SOS1 inhibitor compound as re... |
|
|
Invention
|
Humanized gpc3 antibody and application thereof. Provided is a humanized antibody or antigen-bind... |
|
|
Invention
|
Human cd33 antibody and use thereof. An anti-CD33 antibody and a preparation method therefor and ... |
|
|
Invention
|
Bicyclic compound as hpk1 inhibitor and application thereof. Provided are a compound as represent... |
|
|
Invention
|
Monoclonal antibody for specifically recognizing glypican-3, and application thereof. Provided ar... |
|
|
Invention
|
Sos1 inhibitor, preparation method therefor, and application thereof. The present invention provi... |
|
|
Invention
|
Humanized antibody against tnfr2 and use thereof. Disclosed in the present invention are a humani... |
|
|
G/S
|
Pharmaceutical preparations for the prevention, diagnosis, and treatment of cancer; pharmaceutica... |
|
|
Invention
|
Cdk2/4/6 inhibitor, preparation method therefor, and application thereof. Provided are a compound... |
|
2021
|
Invention
|
Stable pharmaceutical composition.
A stable pharmaceutical composition contains active ingredien... |
|
|
Invention
|
Pharmaceutical composition of aquaporin inhibitor and preparation method thereof.
Provided are a... |
|
|
Invention
|
Use of composition in treatment of cerebral stroke.
Use of a composition in preparation of a dru... |
|
|
Invention
|
Pyrrolidine compound and use thereof.
Disclosed are a pyrrolidine compound as represented by for... |
|
2020
|
Invention
|
Anti-human programmed cell death ligand-1 (pd-l1) antibody and use thereof.
An antibody or antig... |
|
2019
|
G/S
|
Medicated troches; Medicines for the prevention and treatment of cancer, central nervous system d... |
|
|
G/S
|
Troches; medicines for human purposes; biochemical drug;
reagents (chemical -) for medical or ve... |
|
2015
|
G/S
|
Injection (terms considered too vague by the International
Bureau - rule 13.2.b) of the Common R... |
